TVRD
Tvardi Therapeutics
TVRD
TVRD
33 hedge funds and large institutions have $3.21M invested in Tvardi Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$135K | |
| 2 | +$55.9K | |
| 3 | +$10.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.54K |
| 5 |
JPMorgan Chase & Co
New York
|
+$471 |
Top Sellers
| 1 | -$953K | |
| 2 | -$721K | |
| 3 | -$524K | |
| 4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$277K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$129K |
